Viewing Study NCT06309940



Ignite Creation Date: 2024-05-06 @ 8:15 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06309940
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-13
First Post: 2024-03-07

Brief Title: Prognostic Factors for Surgical Management of Large Hypertensive Basal Ganglionic Haemorrhage
Sponsor: Assiut University
Organization: Assiut University

Study Overview

Official Title: Prognostic Factors for Surgical Management of Large Hypertensive Basal Ganglionic Haemorrhage
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study is to present current and comprehensive recommendations for surgical treatment of this hematoma and to determine the factors that may improve the survival rate
Detailed Description: Spontaneous intracerebral hemorrhage is a common mostly deadly stroke subtype and accounts for 10 to 15 of all strokes

Its associated with a higher mortality rate 44 after 30 days than either ischemic stroke or subarachnoid hemorrhage Up to 75 of the long term survivors are often suffering significant disability and only 12 to 39 of the survivors have favourable neurological functions recovered Rapid diagnosis and attentive management of patients is crucial because early deterioration is common Neurosurgical treatment for ICH has been discussed in recent multicentric studies but no definitive answer of its utility has emerged

Improved surgical techniques neuroimaging neuroanesthesia and perioperative monitoring and care have all led to improved outcomes from surgery

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None